Assessment of vaccination strategies against highly pathogenic avian influenza in China

Abstract

Vaccination for highly pathogenic avian influenza (HPAI) has been implemented in China for a decade, however, the virus is still present in poultry. A series of recombinant vaccines, Re-1 to Re-7, have been developed and used, and Re-8 will also be used in clinical settings to prevent the prevailing flu strains. The question remains, when can China eradicate the disease? Here, we review the epidemiology of H5 HPAI along with the development, usage and problems of vaccines. Further suggestions for controlling the disease in China are provided.

Keywords

highly pathogenic avian influenza / vaccine / vaccination / control

References

[1] Hulse-Post D J, Sturm-Ramirez K M, Humberd J, Seiler P, Govorkova E A, Krauss S, Scholtissek C, Puthavathana P, Buranathai C, Nguyen T D, Long H T, Naipospos T S P, Chen H, Ellis T M, Guan Y, Peiris J S M, Webster R G. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proceedings of the National Academy of Sciences of the United States of America, 2005, 102(30): 10682-10687

[2] Chen H L. H5N1 avian influenza in China. Science in China Series C: Life Sciences, 2009, 52(5): 419-427

[3] Xu X, Subbarao K, Cox N J, Guo Y. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology, 1999, 261(1): 15-19

[4] Chen H, Deng G, Li Z, Tian G, Li Y, Jiao P, Zhang L, Liu Z, Webster R G, Yu K. The evolution of H5N1 influenza viruses in ducks in southern China. Proceedings of the National Academy of Sciences of the United States of America, 2004, 101(28): 10452-10457

[5] Zhu Q, Yang H, Chen W, Cao W, Zhong G, Jiao P, Deng G, Yu K, Yang C, Bu Z, Kawaoka Y, Chen H. A naturally occurring deletion in its NS gene contributes to the attenuation of an H5N1 swine influenza virus in chickens. Journal of Virology, 2008, 82(1): 220-228

[6] Tian G, Zhang S, Li Y, Bu Z, Liu P, Zhou J, Li C, Shi J, Yu K, Chen H. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology, 2005, 341(1): 153-162

[7] Li Y, Shi J, Zhong G, Deng G, Tian G, Ge J, Zeng X, Song J, Zhao D, Liu L, Jiang Y, Guan Y, Bu Z, Chen H. Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009. Journal of Virology, 2010, 84(17): 8389-8397

[8] Smith G J D, Fan X H, Wang J, Li K S, Qin K, Zhang J X, Vijaykrishna D, Cheung C L, Huang K, Rayner J M, Peiris J S M, Chen H, Webster R G, Guan Y. Emergence and predominance of an H5N1 influenza variant in China. Proceedings of the National Academy of Sciences of the United States of America, 2006, 103(45): 16936-16941

[9] WHO OIE. Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). Emerging Infectious Diseases, 2008, 14(7): e1

[10] Jiang W M, Liu S, Chen J, Hou G Y, Li J P, Cao Y F, Zhuang Q Y, Li Y, Huang B X, Chen J M. Molecular epidemiological surveys of H5 subtype highly pathogenic avian influenza viruses in poultry in China during 2007-2009. Journal of General Virology, 2010, 91(10): 2491-2496

[11] Smith G J D, Vijaykrishna D, Ellis T M, Dyrting K C, Leung Y H C, Bahl J, Wong C W, Kai H, Chow M K W, Duan L, Chan A S L, Zhang L J, Chen H, Luk G S M, Peiris J S M, Guan Y. Characterization of avian influenza viruses A (H5N1) from wild birds, Hong Kong, 2004-2008. Emerging Infectious Diseases, 2009, 15(3): 402-407

[12] Chen J, Fang F, Yang Z, Liu X, Zhang H, Zhang Z, Zhang X, Chen Z. Characterization of highly pathogenic H5N1 avian influenza viruses isolated from poultry markets in central China. Virus Research, 2009, 146(1-2): 19-28

[13] Boltz D A, Douangngeun B, Phommachanh P, Sinthasak S, Mondry R, Obert C, Seiler P, Keating R, Suzuki Y, Hiramatsu H, Govorkova E A, Webster R G. Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People’s Democratic Republic. Journal of General Virology, 2010, 91(4): 949-959

[14] Nguyen T, Davis C T, Stembridge W, Shu B, Balish A, Inui K, Do H T, Ngo H T, Wan X F, McCarron M, Lindstrom S E, Cox N J, Nguyen C V, Klimov A I, Donis R O. Characterization of a highly pathogenic avian influenza H5N1 virus sublineage in poultry seized at ports of entry into Vietnam. Virology, 2009, 387(2): 250-256

[15] Uchida Y, Mase M, Yoneda K, Kimura A, Obara T, Kumagai S, Saito T, Yamamoto Y, Nakamura K, Tsukamoto K, Yamaguchi S. Highly pathogenic avian influenza virus (H5N1) isolated from whooper swans, Japan. Emerging Infectious Diseases, 2008, 14(9): 1427-1429

[16] Ci Y. Wang D, Fan Z, Liu L, Jia Y, Li X, Tian G, Zeng X, Chen H, Li Y. Biological analysis and pathogenicity of an H5N2 avian influenzavirus isolated from chicken. Chinese Journal of Preventive Veterinary Medicine, 2014, 36(9): 672-675 (in Chinese)

[17] Zhao G, Gu X, Lu X, Pan J, Duan Z, Zhao K, Gu M, Liu Q, He L, Chen J, Ge S, Wang Y, Chen S, Wang X, Peng D, Wan H, Liu X. Novel reassortant highly pathogenic H5N2 avian influenza viruses in poultry in China. PLoS ONE, 2012, 7(9): e46183

[18] Gu M, Liu W, Cao Y, Peng D, Wang X, Wan H, Zhao G, Xu Q, Zhang W, Song Q, Li Y, Liu X. Novel reassortant highly pathogenic avian influenza (H5N5) viruses in domestic ducks, China. Emerging Infectious Diseases, 2011, 17(6): 1060-1063

[19] Zhao K, Gu M, Zhong L, Duan Z, Zhang Y, Zhu Y, Zhao G, Zhao M, Chen Z, Hu S, Liu W, Liu X, Peng D, Liu X. Characterization of three H5N5 and one H5N8 highly pathogenic avian influenza viruses in China. Veterinary Microbiology, 2013, 163(3): 351-357

[20] Qi X, Cui L, Yu H.Whole-genome sequence of a reassortant H5N6 avian influenza virus isolated from a live poultry market in China, 2013. Genome Announcements, 2014, 2(5): e00706-14

[21] Swayne D E, Beck J R, Perdue M L, Beard C W. Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza. Avian Diseases, 2001, 45(2): 355-365

[22] Liu M, Wood J M, Ellis T, Krauss S, Seiler P, Johnson C, Hoffmann E, Humberd J, Hulse D, Zhang Y, Webster R G, Perez D R. Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology, 2003, 314(2): 580-590

[23] Qiao C, Yu K, Jiang Y, Jia Y, Tian G, Liu M, Deng G, Wang X, Meng Q, Tang X. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathology, 2003, 32(1): 25-31

[24] Qiao C, Tian G, Jiang Y, Li Y A N B I N G, Shi J I A N Z H O N G, Yu K A N G Z H E N, Chen H U A L A N. Vaccines developed for H5 highly pathogenic avian influenza in China. Annals of the New York Academy of Sciences, 2006, 1081(1): 182-192

[25] Savill N J, St Rose S G, Keeling M J, Woolhouse M E J. Silent spread of H5N1 in vaccinated poultry. Nature, 2006, 442(7104): 757

[26] Lee C W, Senne D A, Suarez D L. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. Journal of Virology, 2004, 78(15): 8372-8381

[27] Peng Y, Zou Y, Li H, Li K, Jiang T. Inferring the antigenic epitopes for highly pathogenic avian influenza H5N1 viruses. Vaccine, 2014, 32(6): 671-676

[28] Grenfell B T, Pybus O G, Gog J R. Unifying the epidemiological and evolutionary dynamics of pathogens. Science, 2004, 303(5656): 327-332

[29] van der Goot J A, Koch G, De Jong M C M, van Boven M. Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proceedings of the National Academy of Sciences of the United States of America, 2005, 102(50): 18141-18146

[30] Capua I, Marangon S. Control of avian influenza in poultry. Emerging Infectious Diseases, 2006, 12(9): 1319-1324

[31] Beigel J H, Farrar J, Han A M. Avian influenza A (H5N1) infection in humans. New England Journal of Medicine, 2005, 353(13): 1374-1385

[32] Kung N Y, Morris R S, Perkins N R, Sims L D, Ellis T M, Bissett L, Chow M, Shortridge K F, Guan Y, Peiris M J S. Risk for infection with highly pathogenic influenza A virus (H5N1) in chickens, Hong Kong, 2002. Emerging Infectious Diseases, 2007, 13(3): 412-418

[33] Santhia K, Ramy A, Jayaningsih P, Samaan G, Putra A A G, Dibia N, Sulaimin C, Joni G, Leung C Y H, Malik Peiris J S, Wandra T, Kandun N. Avian influenza A H5N1 infections in Bali Province, Indonesia: a behavioral, virological and seroepidemiological study. Influenza and Other Respiratory Viruses, 2009, 3(3): 81-89

[34] Shortridge K F, Gao P, Guan Y, Ito T, Kawaoka Y, Markwell D, Takada A, Webster R G. Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective. Veterinary Microbiology, 2000, 74(1-2): 141-147

[35] Mounts A W, Kwong H, Izurieta H S, Ho Y, Au T, Lee M, Buxton Bridges C, Williams S W, Mak K H, Katz J M, Thompson W W, Cox N J, Fukuda K. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. Journal of Infectious Diseases, 1999, 180(2): 505-508

[36] Ai J, Huang Y, Xu K. Case-control study of risk factors for human infection with influenza A (H7N9) virus in Jiangsu Province, China, 2013. Euro Surveillance : European Communicable Disease Bulletin, 2013, 18(26): 20510

Acknowledgements

This work was supported by the National Basic Research Program (2011CB504702) and the National Science Fund for Distinguished Young Scholars (31025029).

Compliance with ethics guidelines

Honglei Sun and Jinhua Liu declare that they have no conflict of interest or financial conflicts to disclose.

This article does not contain any studies with human or animal subjects performed by any of the authors.

RIGHTS & PERMISSIONS

Higher Education Press and Springer-Verlag Berlin Heidelberg